Skip to main content

Peer Review reports

From: Characteristics, risk factors and a risk prediction model of tocilizumab-induced hypofibrinogenemia: a retrospective real-world study of inpatients

Original Submission
16 Aug 2024 Submitted Original manuscript
24 Oct 2024 Reviewed Reviewer Report
29 Oct 2024 Reviewed Reviewer Report
28 Nov 2024 Author responded Author comments - Man Zhu
Resubmission - Version 2
28 Nov 2024 Submitted Manuscript version 2
10 Dec 2024 Reviewed Reviewer Report
12 Dec 2024 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
17 Dec 2024 Editorially accepted
9 Jan 2025 Article published 10.1186/s40360-024-00827-6

You can find further information about peer review here.

Back to article page